Align Technology, Inc. (NASDAQ:ALGN) Position Boosted by Blair William & Co. IL

Blair William & Co. IL increased its holdings in Align Technology, Inc. (NASDAQ:ALGNGet Rating) by 24.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 161,028 shares of the medical equipment provider’s stock after buying an additional 31,252 shares during the quarter. Blair William & Co. IL’s holdings in Align Technology were worth $105,824,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. BerganKDV Wealth Management LLC grew its holdings in Align Technology by 160.0% in the 3rd quarter. BerganKDV Wealth Management LLC now owns 39 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 24 shares in the last quarter. Harbor Investment Advisory LLC boosted its stake in Align Technology by 200.0% during the 4th quarter. Harbor Investment Advisory LLC now owns 39 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 26 shares in the last quarter. Mizuho Securities Co. Ltd. bought a new position in Align Technology during the 4th quarter valued at $39,000. Clearstead Advisors LLC boosted its stake in Align Technology by 814.3% during the 3rd quarter. Clearstead Advisors LLC now owns 64 shares of the medical equipment provider’s stock valued at $43,000 after purchasing an additional 57 shares in the last quarter. Finally, Altshuler Shaham Ltd bought a new position in Align Technology during the 3rd quarter valued at $47,000. 88.17% of the stock is owned by institutional investors and hedge funds.

Shares of ALGN traded down $8.53 during mid-day trading on Tuesday, reaching $270.18. The company’s stock had a trading volume of 1,194,940 shares, compared to its average volume of 986,443. The business has a fifty day moving average of $366.38 and a 200 day moving average of $495.09. The company has a market cap of $21.29 billion, a price-to-earnings ratio of 30.39, a price-to-earnings-growth ratio of 4.37 and a beta of 1.76. Align Technology, Inc. has a 1 year low of $250.64 and a 1 year high of $737.45.

Align Technology (NASDAQ:ALGNGet Rating) last released its earnings results on Wednesday, April 27th. The medical equipment provider reported $1.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.99 by ($0.29). The business had revenue of $973.22 million during the quarter, compared to analysts’ expectations of $1 billion. Align Technology had a net margin of 17.51% and a return on equity of 19.90%. During the same quarter in the previous year, the company earned $2.51 EPS. Sell-side analysts predict that Align Technology, Inc. will post 8.65 EPS for the current year.

In other news, Director C Raymond Larkin, Jr. acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, May 13th. The stock was acquired at an average cost of $264.42 per share, for a total transaction of $264,420.00. Following the completion of the acquisition, the director now owns 18,190 shares in the company, valued at $4,809,799.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Joseph M. Hogan acquired 6,700 shares of the business’s stock in a transaction that occurred on Wednesday, May 4th. The shares were purchased at an average price of $298.48 per share, with a total value of $1,999,816.00. Following the completion of the acquisition, the chief executive officer now owns 174,801 shares of the company’s stock, valued at approximately $52,174,602.48. The disclosure for this purchase can be found here. 0.64% of the stock is owned by corporate insiders.

A number of equities analysts have issued reports on ALGN shares. TheStreet lowered Align Technology from a “b-” rating to a “c+” rating in a research note on Monday, April 25th. Morgan Stanley decreased their price target on Align Technology from $575.00 to $524.00 in a research note on Thursday, April 28th. Robert W. Baird decreased their price target on Align Technology from $625.00 to $510.00 and set an “outperform” rating for the company in a research note on Thursday, April 28th. StockNews.com initiated coverage on Align Technology in a research note on Thursday, March 31st. They set a “hold” rating for the company. Finally, Piper Sandler cut their price objective on Align Technology from $600.00 to $440.00 in a research report on Thursday, April 28th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $578.27.

Align Technology Company Profile (Get Rating)

Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Read More

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGNGet Rating).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.